Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma

被引:14
作者
Bilbao-Aldaiturriaga, N. [1 ]
Patino-Garcia, A. [2 ]
Martin-Guerrero, I. [1 ]
Garcia-Orad, A. [1 ,3 ]
机构
[1] Univ Basque Country, UPV EHU, Fac Med & Odontol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain
[2] IdiSNA, Inst Invest Sanitaria Navarra, Univ Navarra Clin, Lab Pediat, Pamplona, Spain
[3] BioCruces Hlth Res Inst, Baracaldo, Spain
关键词
CTL Lambda 4; rs231775; vertical bar 49 Lambda/G and osteogenic sarcoma; ANTIGEN-4+49G/A POLYMORPHISM; RISK; SUSCEPTIBILITY; PROMOTER; EXON-1; VARIANTS; CANCER;
D O I
10.4149/neo_2017_218
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Systematic reviews on osteosarcoma have concluded that CTLA4 rs231775 AA genotype influences risk for the disease in the Chinese population. Remarkably, rs231775 shows different frequencies in different human populations. Therefore, it would be interesting to know whether this SNP is related to the risk of osteosarcoma in other populations. The present study aimed to evaluate the association between rs231775 and the susceptibility of osteosarcoma in the Spanish population. We performed an updated meta-analysis including a total of 538 cases and 623 controls. The genotypic association analyses showed that the CTLA4 rs231755 was associated with osteosarcoma susceptibility in the Spanish population. When meta-analysis was performed, the results displayed that CTLA4 rs231775 AA genotype was associated with the risk of developing osteosarcoma in all analyzed populations (OR=2.07; 95% CI: 1.48-2.89). The rs231775 AA genotype could be considered as a susceptibility marker in osteosarcoma.
引用
收藏
页码:299 / +
页数:9
相关论文
共 17 条
[1]
CTLA-4 Expression and Polymorphisms in Lung Tissue of Patients with Diagnosed Non-Small-Cell Lung Cancer [J].
Antczak, Adam ;
Pastuszak-Lewandoska, Dorota ;
Gorski, Pawel ;
Domanska, Daria ;
Migdalska-Sek, Monika ;
Czarnecka, Karolina ;
Nawrot, Ewa ;
Kordiak, Jacek ;
Brzezianska, Ewa .
BIOMED RESEARCH INTERNATIONAL, 2013, 2013
[2]
Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[3]
Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer [J].
Erfani, N ;
Razmkhah, M ;
Talei, AR ;
Pezeshki, AM ;
Doroudchi, M ;
Monabati, A ;
Ghaderi, A .
CANCER GENETICS AND CYTOGENETICS, 2006, 165 (02) :114-120
[4]
Cytotoxic T-Lymphocyte Antigen-4 Genetic Variants and Risk of Ewing's Sarcoma [J].
Feng, Dapeng ;
Yang, Xinghai ;
Li, Shufeng ;
Liu, Tielong ;
Wu, Zhipeng ;
Song, Yuanlin ;
Wang, Jian ;
Gao, Wenwu ;
Huang, Quan ;
Huang, Wending ;
Zheng, Wei ;
Xiao, Jianru .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (06) :458-463
[5]
Fletcher ChristopherDM., 2002, PATHOLOGY GENETICS T, V4
[6]
CTLA-4 gene polymorphism at position+49 A > G in exon 1: a risk factor for cervical cancer in Indian women [J].
Gokhale, Priyanka ;
Kerkar, Shilpa ;
Tongaonkar, Hemant ;
Salvi, Vinita ;
Mania-Pramanik, Jayanti .
CANCER GENETICS, 2013, 206 (05) :154-161
[7]
A Genetic Variant in miR-196a2 Increased Digestive System Cancer Risks: A Meta-Analysis of 15 Case-Control Studies [J].
Guo, Jing ;
Jin, Mingjuan ;
Zhang, Mingwu ;
Chen, Kun .
PLOS ONE, 2012, 7 (01)
[8]
CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers [J].
Hadinia, Abolghasem ;
Hossieni, Seyed Vahid ;
Erfani, Nasrollah ;
Saberi-Firozi, Mehdi ;
Fattahi, Mohammad Javad ;
Ghaderi, Abbas .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (12) :2283-2287
[9]
Primary malignant bone tumors-recent developments [J].
Hameed, Meera ;
Dorfman, Howard .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2011, 28 (01) :86-101
[10]
Cytotoxic T-Lymphocyte Antigen-4+49G/A Polymorphism and Susceptibility to Pancreatic Cancer [J].
Lang, Cuicui ;
Chen, Lei ;
Li, Senlin .
DNA AND CELL BIOLOGY, 2012, 31 (05) :683-687